Semaglutide vs Tirzepatide: Which one to choose?

Last reviewed: June 16, 2026

Last updated: June 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Both semaglutide and tirzepatide are injectable medications approved by the FDA for weight management, but they work through different biological mechanisms. Tirzepatide acts on two hormone pathways—GLP-1 and GIP—while semaglutide targets only the GLP-1 pathway. Understanding these differences can help you and your healthcare provider select the medication most likely to work for your unique physiology.

How Semaglutide and Tirzepatide Work Differently

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a natural hormone that slows stomach emptying, reduces hunger signals, and improves blood sugar control. By binding to GLP-1 receptors throughout the brain and digestive system, semaglutide creates feelings of fullness and decreases food cravings. This single-pathway mechanism has demonstrated consistent weight loss results in multiple clinical studies.

Tirzepatide operates as a dual agonist, meaning it activates both GLP-1 and glucose-dependent insulinotropic peptide (GIP) receptors simultaneously. The addition of GIP activation may enhance insulin secretion and metabolic rate, potentially explaining why some patients experience more significant weight reduction with tirzepatide compared to semaglutide alone. Research suggests this dual-action approach addresses appetite and metabolism through complementary biological channels.

Tirzepatide vs Semaglutide: Clinical Trial Outcomes

Head-to-head clinical trials have consistently shown that tirzepatide produces greater average weight loss than semaglutide at equivalent dose levels. In the SURMOUNT-1 trial, participants using tirzepatide achieved approximately 22% body weight reduction, while semaglutide studies typically show 15-17% reductions. However, individual responses vary significantly based on genetics, lifestyle, and starting weight, meaning some patients respond exceptionally well to semaglutide alone.

Beyond weight loss, both medications improve cardiovascular risk factors including blood pressure and cholesterol levels. Tirzepatide has shown additional benefits in reducing liver fat content and improving insulin sensitivity markers more dramatically than semaglutide in certain patient populations. These differences suggest that tirzepatide may be particularly beneficial for individuals with metabolic dysfunction or those seeking maximum weight reduction impact.

Genetics Play a Role in Medication Response

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Patients carrying certain genetic variants may experience superior outcomes with tirzepatide's dual-action approach, while others may achieve excellent results with semaglutide's single-pathway mechanism. Genetic testing removes guesswork from medication selection and can accelerate your path to effective weight management by matching you with the compound most likely to work with your biology, not against it.

Choosing Your Medication: Semaglutide or Tirzepatide

Semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and remains the most accessible entry point for GLP-1 therapy through PlexusDx. Your dose may need to go up. Your price won't. Semaglutide is ideal if you're new to GLP-1 medications, have mild to moderate weight loss goals, or prefer starting with a single-pathway approach before considering combination therapy.

Tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) and offers dual-pathway activation for patients seeking maximum weight loss potential or those who haven't achieved their goals with semaglutide alone. PlexusDx also offers GLP-Squared Injection ($289/mo), which combines both compounds for patients who benefit from simultaneous single-pathway and dual-pathway activation. All medications come from licensed 503A compounding pharmacies, work in all 50 states without insurance, and are HSA/FSA eligible.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Will tirzepatide work better for me than semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

What does clinical evidence show about these medications?

The SURMOUNT-1 trial demonstrated tirzepatide achieves approximately 22% body weight reduction, while semaglutide trials typically show 15-17% reductions. Both medications improve blood pressure, cholesterol, and cardiovascular markers. Tirzepatide additionally improves liver fat content and insulin sensitivity more dramatically in some patient populations, suggesting it may benefit those with metabolic dysfunction.

How much does each medication cost through PlexusDx?

Semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), while tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan). Your dose may need to go up. Your price won't. Both are available without insurance across all 50 states and qualify for HSA/FSA spending accounts. Add the Precision Peptide Genetic Test ($298) after your first month to optimize your medication choice.

Are side effects different between semaglutide and tirzepatide?

Both medications commonly cause nausea, vomiting, and constipation during dose escalation, typically decreasing as your body adapts. Tirzepatide may cause slightly more gastrointestinal side effects due to dual-pathway activation, though most patients tolerate both well. Severe side effects are rare when prescribed through licensed compounding pharmacies with proper medical oversight.

How does genetic testing help me choose between these medications?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Semaglutide Vs Tirzepatide 2
• Tirzepatide Vs Semaglutide 2
• Tirzepatide Vs Semaglutide Side Effects
• Semaglutide Or Tirzepatide

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.